In Veritas Medical Diagnostics, Inc. (IVME) Comparison with companies in other sectors?

In Veritas Medical Diagnostics, Inc. has a share price of 86.05M. You can analyze In Veritas Medical Diagnostics, Inc. (IVME) competitors across different market sectors through stock heatmaps.

What are IVME's NET and operating margins?

In Veritas Medical Diagnostics, Inc. (IVME) operating margin is around 0.00, and net profit margin is approximately 0.00 as of the latest reports.

In what way does IVME's earnings per share (EPS) trend reflect its financial momentum?

In Veritas Medical Diagnostics, Inc. (IVME) EPS is -15.30 (If EPS value is positive, then “signals consistent profit growth” if Negative then “signals consistent loss”). This metric is also critical in assessing valuation metrics like the P/E ratio for In Veritas Medical Diagnostics, Inc. is -0.02, and the company’s ability to reinvest or distribute profits.

What does a high ROE mean for In Veritas Medical Diagnostics, Inc.?

A high ROE suggests efficient use of shareholder equity to generate profit. It often signals strong management and profitability.

How do I know if AAPL is overvalued or undervalued?

Check valuation ratios for In Veritas Medical Diagnostics, Inc. like P/E which is -239.47, P/B which is -3.68, and PEG which is -2.39. Compare them with sector averages to evaluate if the stock is priced fairly.

In Veritas Medical Diagnostics, Inc.

IVME•PNK

Financial Services

Shell Companies

$0.30

$0.00(0.00%)

In Veritas Medical Diagnostics, Inc. (IVME) Fundamental Analysis: Financial Health, Valuation, and Key Ratios

Dive into Apple Inc.’s fundamentals including valuation ratios, profitability, efficiency metrics, and financial health. Use this data to assess long-term investment quality and compare it with sector benchmarks.

EPS (TTM)

$-15.30

P/E Ratio

-0.02

ROE

0.02%

Net Margin

Key Financial Metrices

Valuation Metrics

4 metrics

Market CapTotal market value of outstanding shares

$25.81M

Shares OutstandingTotal number of shares issued

$86.05M

Book Value/ShareNet worth per share

$-0.08

Revenue/ShareAnnual revenue per share

Profitability Metrics

6 metrics

EPS (TTM)Earnings per share trailing twelve months

$-15.3

Net MarginNet income as percentage of revenue

Operating MarginOperating income as percentage of revenue

ROEReturn on shareholders' equity

1.86%

ROAReturn on total assets

-96.30%

ROCEReturn on capital employed

1.70%

Cash Flow Metrics

3 metrics

Free Cash Flow/ShareCash generated per share after capex

$-0.01

Cash/ShareCash and equivalents per share

FCF YieldFree cash flow as percentage of market cap

-3.09%

Dividend Metrics

2 metrics

Dividend/ShareAnnual dividend payment per share

Dividend YieldAnnual dividend as percentage of stock price

Financial Ratios Analysis data is not available for IVMEFinancial Ratios Analysis details for IVME are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Sector Benchmarking data is not available for IVMESector Benchmarking details for IVME are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Understanding Fundamental Analysis for In Veritas Medical Diagnostics, Inc. Investment Decisions

What is Fundamental Analysis?

Fundamental analysis is a method used to assess the intrinsic value of In Veritas Medical Diagnostics, Inc.. Using financial reports, management structure, competitive position, and market environment, investors can determine whether the stock is undervalued or overvalued. This analysis helps investors like you make more informed investment decisions, taking into account In Veritas Medical Diagnostics, Inc.'s unique business strengths and challenges.

Key Financial Metrics for In Veritas Medical Diagnostics, Inc.

For In Veritas Medical Diagnostics, Inc., essential financial indicators include EPS -15.30, PE -0.02, and ROE 0.02. These key ratios reveal insights into In Veritas Medical Diagnostics, Inc.'s profitability, valuation, and operational health. Understanding these metrics enables you to compare In Veritas Medical Diagnostics, Inc. with its industry peers and decide whether it presents a viable investment opportunity.

Profitability and Operational Efficiency of In Veritas Medical Diagnostics, Inc.

Metrics like Net Margin - and ROA -96.30% shed light on how well In Veritas Medical Diagnostics, Inc. is generating profits. A high profitability ratio often indicates strong management and a solid business model, which are essential for long-term growth. These metrics are crucial in assessing whether In Veritas Medical Diagnostics, Inc. can sustain its operations and continue growing in the future.

Valuation and Market Position of In Veritas Medical Diagnostics, Inc.

Using ratios such as P/B Ratio -3.68 and PEG Ratio -2.39, investors can assess whether In Veritas Medical Diagnostics, Inc. is appropriately valued based on its financials and growth potential. These figures, combined with In Veritas Medical Diagnostics, Inc.'s market capitalization, give insight into its competitive positioning and investor expectations, helping you make informed decisions on pricing and value.

Financial Health and Risk Assessment for In Veritas Medical Diagnostics, Inc.

Financial health indicators, such as Debt/Equity Ratio -0.52 and Cash Flow $-0.01, provide a snapshot of In Veritas Medical Diagnostics, Inc.'s ability to meet financial obligations and handle economic setbacks. A company with a strong balance sheet and solid cash flow, like In Veritas Medical Diagnostics, Inc., is more likely to weather financial storms, making it a safer investment.

Long-Term Investment Strategy for In Veritas Medical Diagnostics, Inc.

Investing in In Veritas Medical Diagnostics, Inc. based on fundamental analysis emphasizes long-term business growth rather than short-term market trends. Investors looking at In Veritas Medical Diagnostics, Inc. focus on its solid financial performance, industry standing, and competitive advantages, all of which suggest sustainable growth and the potential for steady returns over time.

Fundamental Analysis FAQ

;